Susquehanna International Group’s Elevation Oncology ELEV Stock Holding History

Susquehanna International Group’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,010,308	Closed	-$371K	–	12713
2025 Q2	$371K	Buy	1,010,308 +941,871	+1,376%	+$314K	﹤0.01%	9864
2025 Q1	$17.7K	Buy	68,437 +30,512	+80%	+$17.4K	﹤0.01%	12138
2024 Q4	$21.3K	Buy	+37,925	New	+$22.4K	﹤0.01%	11904
2022 Q1	–	Sell	-11,201	Closed	-$67K	–	13196
2021 Q4	$67K	Buy	+11,201	New	+$77.3K	﹤0.01%	12404

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Susquehanna International Group's ELEV Position: Q3 2025 in Review

Susquehanna International Group sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 1,010,308 shares — an estimated $371K sold.

Susquehanna International Group first reported a position in ELEV in Q4 2021 and held it in 4 quarters. The position peaked at $371K in Q2 2025. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

Susquehanna International Group reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
Susquehanna International Group sold 1,010,308 Elevation Oncology shares in Q3 2025, an estimated $371K.
Susquehanna International Group first reported a position in Elevation Oncology in Q4 2021 and held it in 4 quarters.
Susquehanna International Group's Elevation Oncology position peaked at $371K in Q2 2025.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.